News

Particle Health Achieves Certification for Advanced Medication Solutions

Particle Health Achieves Certification for Advanced Medication Solutions

Particle Health Secures Certification for Surescripts Medication History

In a groundbreaking development, Particle Health has announced its completion of certification for Surescripts Medication History for Populations. This milestone further cements Particle Health’s position as a trailblazer in the healthcare data landscape. Through this certification, the company is focused on enhancing patient insights, which is vital for improving the overall healthcare experience.

Understanding the Importance of Medication History

Medication History for Populations is a game changer for various healthcare institutions, including health systems, hospitals, and health plans. This innovative tool aids in managing cost-effective care by providing essential medication history and prescription notifications. By deploying this service, Particle Health's clients will gain access to real-time medication lists for their patients. This capability helps healthcare providers monitor whether patients are adhering to their prescribed medications. Early identification of non-adherence allows for timely intervention, potentially preventing severe complications or hospital admissions.

The Voice of Leadership

Jason Prestinario, the CEO of Particle Health, emphasizes the significance of this certification. He states, "For many of us, the medications we take each day are the most frequent way we interact with the health system. Enabling care providers with clinical insights that provide a more complete picture of a patient's overall care experience is essential to being able to improve medication adherence." His vision underscores how these tools will empower healthcare providers to aid patients in adhering to their medications, enhancing treatment effectiveness, and ensuring better health outcomes.

Enhancing Patient Safety and Care Quality

Medication adherence is vital for ensuring patient safety, significantly for vulnerable populations. With Medication History for Populations, clients of Particle Health can efficiently access current data that highlights gaps in care through effective panel management and prescription notifications. This accessibility is invaluable, especially as it brings medication data from nearly all significant pharmacy chains and pharmacy benefit managers, enabling clinicians to identify patients at risk of non-adherence, adverse drug events (ADEs), or drug misuse.

Collaboration with Industry Leaders

Matt Hartzler, Director of Product Innovation at Surescripts, expressed excitement regarding Particle Health’s engagement with the Medication History for Populations solution, which amplifies efforts to boost medication adherence. He explained that the tool provides a comprehensive perspective of a patient's medication practices, revealing opportunities to enhance adherence and close any care gaps.

The Statistics behind Medication Adherence

Statistics from authoritative sources reveal that medication non-adherence leads to significant treatment failures and hospitalizations. Alarmingly, up to 50% of treatment failures can be traced back to patients not following their prescribed medications, which poses a critical challenge in healthcare management. This issue is even more pronounced in patients with chronic illnesses, where adherence rates hover around just 50%.

Integration with Health Technology

Particle Health has recently passed extensive testing and certification with Surescripts, which enhances its proficiency in utilizing the Surescripts Medication History for Populations. With this addition, Particle Health joins an esteemed alliance of electronic health record vendors, pharmacy benefit managers, and healthcare organizations. This diverse network will collectively work towards improving care quality and patient safety.

Surescripts is recognized for its commitment to providing reliable, secure, and scalable healthcare solutions. With stringent security protocols and network integrity measures, it ensures that all participants in the network are compliant and that patient data remains accurate and complete.

Discover More about Particle Health

For additional details regarding Particle Health’s certification and the influence of Surescripts Medication History for Populations on medication adherence, interested parties are encouraged to explore Particle Health’s resources and offerings.

About Particle Health

Particle Health is dedicated to transforming healthcare through intelligent data integration. Their mission focuses on leveraging medical records to concentrate on patient care. By interfacing with national and state medical record exchanges, Particle Health enhances interoperability and medical record sharing. This infrastructure grants access to extensive clinical data on millions of patients, facilitating the delivery of critical insights through advanced technologies, including machine learning and AI.

Frequently Asked Questions

What is Surescripts Medication History for Populations?

Surescripts Medication History for Populations is a solution that provides healthcare organizations with comprehensive medication history, improving patient care and adherence.

How does Particle Health utilize this certification?

Particle Health employs the certification to enhance its data services that aggregate actionable patient insights, directly supporting healthcare providers in improving medication adherence.

Why is medication adherence crucial in healthcare?

Medication adherence is key to patient safety and effective treatment, as it significantly reduces the risks of treatment failure and hospitalizations.

Who can benefit from Particle Health's services?

Healthcare systems, hospitals, accountable care organizations, and health plans can benefit from Particle Health's services in managing patient care more effectively.

What impact does non-adherence have on healthcare costs?

Non-adherence to medications can lead to increased healthcare costs due to preventable treatment failures and unnecessary hospital stays, emphasizing the need for effective adherence strategies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

IntelliGenome Partners with NL Diagnóstica for TB Battle

Updated Category News Views 133

Breaking New Ground in Tuberculosis Detection When IntelliGenome, a Houston-based developer of CRISPR-based diagnostic tech, teams up with São Paulo's veteran player NL Diagnóstica, you know they're onto something game-changing. This partnership is all about taking the fight against tuberculosis in Brazil to new heights with their CRISPR-Dx™ diagnostic platform. Not...

Continue Reading
Tennessee Highlights Alarming COPD Rates This November

Updated Category News Views 49

Tennessee Turns the Spotlight on COPD Here we are again, looking at Tennessee with its weary lung health woes. Governor Bill Lee's newest proclamation for November as COPD Awareness Month is shining a light on a crisis that's been disproportionately hitting the state harder than a sideswipe from a semi. Why the Proclamation Matters Let's cut through the fog—COPD,...

Continue Reading
Fresha Teams with Klarna: Shaking Up Beauty Payments

Updated Category News Views 126

New Flexibility at the Beauty Checkout Hey, if you've ever paced back and forth considering signing up for that luxury self-care spree, well, Fresha’s latest move might just tip the scales. The beauty and wellness booking giant has partnered with Klarna, diving headfirst into the Buy Now, Pay Later (BNPL) craze. It's about time, right? Everyone loves a good spa session,...

Continue Reading
Emergys and Glean Rearrange AI Puzzle for Enterprises

Updated Category News Views 132

Enterprises on AI: From Dreams to Doing Alright, here’s a nugget for you: AI isn't just pie-in-the-sky jazz anymore. Some folks are finally bringing it down to Earth. Emergys, a player in digital transformation, is shaking hands with Glean, renowned for their enterprise AI chops, to turn enterprise chaos into clarity. It's all about squeezing out real returns and...

Continue Reading
Consumer Electronics Boom: Profits Soar Till 2035

Updated Category News Views 0

Riding the Electronics Tsunami The consumer electronics sector isn't just catching a wave; it's barreling through a technological tsunami. Projected to leap from USD 1100.87 billion in 2026 to USD 2825.55 billion by 2035, we're talking a whopping 11.04% CAGR. It's driven by none other than the smartphone frenzy, intelligent computing advances, and the almighty connected...

Continue Reading
Exploring 'Deeper Prayer': A Journey with Apostle Paul

Updated Category News Views 143

A Deep Dive into the Prayers of Apostle Paul Gary P. Rohrmayer's latest devotional takes believers on a unique journey, exploring the Apostle Paul's prayers across his missionary paths. But don't expect just another preacher prophesying from the pulpit. This is more like peeling back layers of history, bit by bit. 28 Days of Spiritual Insights Each day within the book...

Continue Reading
Northwind Backs Huge Office-to-Residential Overhaul

Updated Category News Views 172

In the Heart of Midtown: A Major Overhaul I'm telling ya, if there's a piece of news that makes me sit up straight this morning over the breakfast bar, it's this colossal $231 million construction loan announcement by Northwind Group. They're turning 675 Third Avenue, a towering 32-story office behemoth smack in Midtown, into residential apartments. Right here in...

Continue Reading
Potomac Edison Targets Virginia Grid Revamp by 2030

Updated Category News Views 82

Strengthening the Backbone of Virginia's Power Supply Ever had your lights flicker on a windy day and wondered if the power grid would hold? Potomac Edison, under the banner of FirstEnergy Corp., is stepping up with a game plan to fortify the electric spine of Virginia and its neighbors. They're diving into a multi-state adventure, rebuilding and erecting 138 kV...

Continue Reading
Magnolia's Data Breach Raises Eyebrows and Concerns

Updated Category News Views 84

Data Security Breach: Today's Digital Nightmare In the relentless digital jungle we live in, someone’s email account is like a treasure trove for cybercriminals sniffing around for their next haul. And that’s precisely what went down at Magnolia Management Company, LLC out in East Longmeadow, Massachusetts. It was April 3, 2026, when they stumbled upon some...

Continue Reading
Vantage's Pre-IPO CFD: New Frontier or Gamble?

Updated Category News Views 146

Ah, the thrill of the pre-IPO buzz. Vantage has thrown its hat into the ring with a pre-IPO CFD offering, giving stock jockeys like you and me a chance to express our bullish or bearish convictions before a company goes public. The question is: does this open new doors for the sharp-eyed investor, or are we just adding another layer of risk onto an already wild ride?...

Continue Reading

Top 5 Most Recently Viewed Articles

Legal Action Review for Lineage, Inc. Investors - Take Note

Updated Category News Views 122

Overview of Legal Issues Facing Lineage, Inc. Investors should be aware of important developments regarding Lineage, Inc. This leading company is currently facing a class action securities lawsuit. This news has garnered attention as it deeply impacts shareholders and signifies the need for vigilance within the investment community. What is the Class Action Lawsuit About?...

Continue Reading
Midnight Hub Investors Urged to Act on Class Action Opportunity

Updated Category News Views 102

Investors Alert: Class Action Lawsuit Opportunity for Midnight Hub NFT Holders In a significant development for investors affiliated with Midnight Hub, Bronstein, Gewirtz & Grossman, LLC has formally announced a riveting class action lawsuit directed at individuals who acquired ROOMS non-fungible tokens (NFTs) and Digital Nomads NFTs. These digital assets, issued by...

Continue Reading
Exploring the Synergy of AI and Blockchain in Finance

Updated Category News Views 229

The Transformative Power of AI and Blockchain In the rapidly evolving world of finance, the integration of artificial intelligence (AI) and blockchain technology is heralding a new era. As digital markets expand, the sheer volume and speed of data can be overwhelming for traditional processing methods. This is where artificial intelligence steps in, restructuring...

Continue Reading
TeraWatt Tech Snags Battery Vet Dr. Kang for Innovation Boost

Updated Category News Views 5

Next Big Leap in Battery Tech? Dr. Sunho Kang's arrival at TeraWatt Technology is the kind of news that makes folks in the energy sector sit up and take notice. With more than 25 years under his belt handling battery innovations from lab to factory floor, Kang's move smells like a game-changer for TeraWatt. If you don't know already, TeraWatt’s not just dabbling in...

Continue Reading
Nuvation Bio's Upcoming Results: Trading the Oncology Gamble?

Updated Category News Views 166

Nuvation Bio Inc. (NYSE: NUVB) is set to drop its financial results for Q4 and the full year of 2025 on March 2, 2026. Mark your calendars—this one could be a rollercoaster ride for traders. The oncology firm’s got a diversified pipeline packed with heavy-hitters like taletrectinib and safusidenib, but the real question is whether these treatments will convert into...

Continue Reading